Table 1 Demographic information and study parameters in moderate (n = 372 eyes) and high (n = 171 eyes) myopic patients treated with SMILE, femto-LASIK, and PRK in this study
Moderate myopia | High myopia | ||||||
|---|---|---|---|---|---|---|---|
SMILE | femto-LASIK | PRK | SMILE | femto-LASIK | PRK | ||
Number of eyes | 124 | 124 | 124 | 57 | 57 | 57 | |
Age (years) | 28.02 ± 5.22 | 28.21 ± 4.71 | 28.31 ± 6.32 | 27.76 ± 6.39 | 30.29 ± 7.63 | 28.79 ± 7.00 | |
Sex (F) | 66.1 % | 62.9 % | 64.5 % | 61.8 % | 58.8 % | 63.6 % | |
ACT (µm) | 561.08 ± 25.88 | 561.03 ± 25.88 | 560.73 ± 25.87 | 544.56 ± 17.26 | 551.00 ± 16.50 | 543.62 ± 18.66 | |
Removal tissue thickness (µm) | 106.63 ± 13.51 | 76.43 ± 13.79 | 73.41 ± 13.61 | 143.53 ± 16.28 | 112.33 ± 11.63 | 112.56 ± 12.38 | |
MRSE (D) | Pre-op | -4.66 ± 0.85 | -4.47 ± 0.82 | -4.36 ± 0.72 | -7.54 ± 0.92 | -7.19 ± 0.61 | -7.79 ± 1.37 |
After 12 M | 0.15 ± 0.34 | -0.00 ± 0.33 | 0.10 ± 0.35 | -0.05 ± 0.47 | -0.31 ± 0.28 | -0.27 ± 0.58 | |
Astigmatism (D) | Pre-op | -1.00 ± 0.80 | -0.80 ± 0.58 | -0.93 ± 0.71 | -1.64 ± 1.15 | -1.56 ± 1.41 | -1.51 ± 0.91 |
After 12 M | -0.40 ± 0.40 | -0.39 ± 0.29 | -0.45 ± 0.29 | -0.57 ± 0.53 | -0.50 ± 0.05 | -0.37 ± 0.20 | |
UDVA (logMAR) | Pre-op | 1.40 ± 0.26 | 1.37 ± 0.28 | 1.40 ± 0.14 | 1.75 ± 0.15 | 1.62 ± 0.33 | 1.73 ± 0.21 |
After 12 M | 0.01 ± 0.03 | 0.00 ± 0.00 | 0.00 ± 0.02 | 0.01 ± 0.03 | 0.02 ± 0.06 | 0.05 ± 0.13 | |
CDVA (logMAR) | Pre-op | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.01 ± 0.03 | 0.00 ± 0.00 | 0.02 ± 0.04 |
After 12 M | 0.00 ± 0.01 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.01 ± 0.02 | 0.01 ± 0.02 | |
Safety index | 0.99 ± 0.03 | 1.00 ± 0.00 | 1.00 ± 0.00 | 1.04 ± 0.07 | 0.98 ± 0.04 | 1.04 ± 0.07 | |
Efficacy index | 0.99 ± 0.02 | 1.00 ± 0.00 | 1.00 ± 0.00 | 1.04 ± 0.07 | 0.98 ± 0.04 | 1.04 ± 0.07 | |